Many investigators in different parts of the world have determined their own starting dose for capecitabine, usually based on their experience of toxic events within the population of patients ...

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw ...

CHICAGO -- A neoadjuvant chemotherapy regimen of cisplatin (Platinol), nab-paclitaxel (Abraxane), capecitabine (Xeloda), and ...

If they suffer no major toxicity, the dose is increased. Emily Alimonti, a 42-year-old biotech salesperson in upstate New York, chose that path before starting capecitabine treatment in December.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Number_i Last week Weeks at no. 1 Weeks on chart Week of May 31, 2025 click to see more Loading... Send us a tip using our anonymous form. A daily briefing on what matters in the music industry ...

The playful pop purveyor spent a record 21 weeks at Number 1 in 2024 – more than any other artist has managed in a calendar year – with her chart-topping hits Espresso, Please Please Please ...

Commissions do not affect our editors' opinions or evaluations. The RACI chart has long been a popular tool among project managers around the world. Also referred to as the RACI matrix ...

The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib and abrocitinib.

Morgan Wallen Last week Weeks at no. 1 Weeks on chart M.C.Wallen, G.W.Block, J.McLaughlin, E.K.Smith, Charlie Handsome J.Moi, Charlie Handsome Mercury/Republic/Big Loud Week of June 7, 2025 click ...

Johnson & Johnson has claimed FDA approval for new formulation of its blockbuster multiple myeloma drug Darzalex that cuts its dosing time to just a few minutes from hours and could help it fend ...

Roche has stopped dosing in a phase 3 trial of tominersen, a potential Huntington’s disease (HD) drug developed with Ionis, after a pre-planned review by independent experts.